Memorial Sloan Kettering Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
BCMA Targeted CAR T Cells With or Without Lenalidomide for the Treatment of Multiple Myeloma
- Conditions
- Multiple Myeloma
- Interventions
- First Posted Date
- 2017-03-03
- Last Posted Date
- 2024-03-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT03070327
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver
- Conditions
- Colorectal Adenocarcinoma Metastatic to the Liver
- Interventions
- First Posted Date
- 2017-03-03
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT03069950
- Locations
- 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memoral Sloan Kettering Westchester, Harrison, New York, United States
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
- First Posted Date
- 2017-03-03
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 21
- Registration Number
- NCT03070301
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Md Anderson Cancer Center, Houston, Texas, United States
Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer
- Conditions
- Prostate Cancer
- Interventions
- Drug: DegarelixRadiation: stereotactic body radiosurgery (SBRT)
- First Posted Date
- 2017-02-17
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 56
- Registration Number
- NCT03056638
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
🇺🇸Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
Investigation of the Effects of Electronic Cigarettes on Vascular Health
- Conditions
- Vascular Health
- Interventions
- Behavioral: Electronic cigaretteBehavioral: (sham cigarette) - no actual exposure to cigarettesBehavioral: traditional cigarette
- First Posted Date
- 2017-02-02
- Last Posted Date
- 2021-06-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT03041493
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Assessing How Normal Variations in CT Scanning Affects Its Interpretation
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- Diagnostic Test: CT scan
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 169
- Registration Number
- NCT03038568
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸MD Anderson Cancer Center, Texas (Data collection only), Houston, Texas, United States
Predicting Effective Therapy in Pancreatic Cancer
- Conditions
- Pancreatic AdenocarcinomaPancreatic Cancer
- Interventions
- Diagnostic Test: CTC isolocation and analysis
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2024-04-25
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 74
- Registration Number
- NCT03033927
- Locations
- 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸Memorial Sloan Kettering Cancer Center Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Memorial Sloan Kettering Cancer Center @ Suffolk, Commack, New York, United States
A(B)VD Followed by Nivolumab as Frontline Therapy for Higher Risk Patients With Classical Hodgkin Lymphoma (HL)
- Conditions
- Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2024-11-20
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 82
- Registration Number
- NCT03033914
- Locations
- 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸Hackensack Meridian Health, Hackensack, New Jersey, United States
🇺🇸Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma
- Conditions
- Neuroblastoma
- Interventions
- First Posted Date
- 2017-01-26
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 59
- Registration Number
- NCT03033303
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Conditions
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)Prostate Cancer
- Interventions
- First Posted Date
- 2017-01-25
- Last Posted Date
- 2019-04-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT03030885
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States